Complications Experienced During Right Heart Catheterisation in a Non-Fasted Anti-Coagulated Population

12.50
Hdl Handle:
http://hdl.handle.net/10755/303972
Category:
Abstract
Type:
Presentation
Title:
Complications Experienced During Right Heart Catheterisation in a Non-Fasted Anti-Coagulated Population
Author(s):
Prichard, Roslyn A.; Phan, Justin Anh-Kiet; Davidson, Patricia Mary; Hayward, Christopher S.; Keogh, Anne Margaret; Harris, Jacqueline L.
Lead Author STTI Affiliation:
Non-member
Author Details:
Roslyn A. Prichard, RN, BA, Grad Dip CCU/ICU, rprichard@stvincents.com.au; Justin Anh-Kiet Phan, MBBS; Patricia Mary Davidson, RN, BA, MEd, PhD, FRCNA; Christopher S. Hayward, BMedSc, MBBS, MD, FRACP, FCANZ, MD; Anne Margaret Keogh, FRACP, MD, MBBS, FRCSANZ; Jacqueline L. Harris, MBBS, FRACP;
Abstract:

Poster presented on: Wednesday, July 24, 2013, Thursday, July 25, 2013

Purpose: Describe incidence of complications during Right Heart Catheterisation in a non fasted and anti coagulated population. Examine how we report complications and the implications for program management and benchmarking our practice.

Methods: Review of 1429 RHCs between January 2008 and June 2012.  Patients were not fasted, anti coagulation therapy was not ceased and patients were not routinely admitted.

581 patients records were reviewed by medical staff, the last 848 involved interrogation of a clinical database.

Adverse events were defined as either events caused by the RHC, which required intervention to treat or prevent an adverse outcome, were medically significant, resulted in an unexpected admission, or were life threatening. (Definition A) 

Or  in addition prolonged a procedure, required abandonment of the procedure or otherwise  impacted on program resources. (Definition B) 

Chi square analysis determined the significance of  anti coagulation on bleeding complications in the first 581 patients.

Results: Between 2008 and 2009 581 procedures were performed. Adverse event rate (Def A)was 4.3%.

Chi square analysis of bleeding complications and warfarinisation on bleeds gave  p=0.11

Between 2010 and 2012 a further 848 RHCs were assessed through interrogation a clinical database and revealed an event rate of between 4.8% (Def A) and 7.2% (Def B).

We describe acute musculoskeletal, respiratory, haemodynamic and anaphylactic  events. 

Conclusion:  Being un fasted had no effect on adverse events and allowed real life haemodynamic data to be collected. Bleeding complications were minor and being anti-coagulated made no difference to the event rate in the first 581 patients. (p=0.24). Difficulty obtaining access and a knotted catheter support the need for flouroscopy and ultrasound guidance in high volume services.

Overall our adverse event rate is comparable to rates described in the literature, and supports our current practice as safe. However rigorous attention should be paid to how and why events are described as complications.
Keywords:
Right Heart Catheterisation; Complication; Anti Coagulation
Repository Posting Date:
22-Oct-2013
Date of Publication:
22-Oct-2013
Conference Date:
2013
Conference Name:
24th International Nursing Research Congress
Conference Host:
Sigma Theta Tau International, the Honor Society of Nursing
Conference Location:
Prague, Czech Republic
Description:
24th International Nursing Research Congress Theme: Bridge the Gap Between Research and Practice Through Collaboration. Held at the Hilton Prague Hotel.
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission.

Full metadata record

DC FieldValue Language
dc.language.isoen_USen_GB
dc.type.categoryAbstracten_GB
dc.typePresentationen_GB
dc.titleComplications Experienced During Right Heart Catheterisation in a Non-Fasted Anti-Coagulated Populationen_GB
dc.contributor.authorPrichard, Roslyn A.en_GB
dc.contributor.authorPhan, Justin Anh-Kieten_GB
dc.contributor.authorDavidson, Patricia Maryen_GB
dc.contributor.authorHayward, Christopher S.en_GB
dc.contributor.authorKeogh, Anne Margareten_GB
dc.contributor.authorHarris, Jacqueline L.en_GB
dc.contributor.departmentNon-memberen_GB
dc.author.detailsRoslyn A. Prichard, RN, BA, Grad Dip CCU/ICU, rprichard@stvincents.com.au; Justin Anh-Kiet Phan, MBBS; Patricia Mary Davidson, RN, BA, MEd, PhD, FRCNA; Christopher S. Hayward, BMedSc, MBBS, MD, FRACP, FCANZ, MD; Anne Margaret Keogh, FRACP, MD, MBBS, FRCSANZ; Jacqueline L. Harris, MBBS, FRACP;en_GB
dc.identifier.urihttp://hdl.handle.net/10755/303972-
dc.description.abstract<p>Poster presented on: Wednesday, July 24, 2013, Thursday, July 25, 2013</p><b>Purpose: </b> Describe incidence of complications during Right Heart Catheterisation in a non fasted and anti coagulated population. Examine how we report complications and the implications for program management and benchmarking our practice. <p><b>Methods: </b> Review of 1429 RHCs between January 2008 and June 2012.  Patients were not fasted, anti coagulation therapy was not ceased and patients were not routinely admitted. <p>581 patients records were reviewed by medical staff, the last 848 involved interrogation of a clinical database. <p>Adverse events were defined as either events caused by the RHC, which required intervention to treat or prevent an adverse outcome, were medically significant, resulted in an unexpected admission, or were life threatening. (Definition A)  <p>Or  in addition prolonged a procedure, required abandonment of the procedure or otherwise  impacted on program resources. (Definition B)  <p>Chi square analysis determined the significance of  anti coagulation on bleeding complications in the first 581 patients. <p><b>Results: </b> Between 2008 and 2009 581 procedures were performed. Adverse event rate (Def A)was 4.3%. <p>Chi square analysis of bleeding complications and warfarinisation on bleeds gave  <em>p</em>=0.11 <p>Between 2010 and 2012 a further 848 RHCs were assessed through interrogation a clinical database and revealed an event rate of between 4.8% (Def A) and 7.2% (Def B). <p>We describe acute musculoskeletal, respiratory, haemodynamic and anaphylactic  events.  <p><b>Conclusion: </b>  Being un fasted had no effect on adverse events and allowed real life haemodynamic data to be collected. Bleeding complications were minor and being anti-coagulated made no difference to the event rate in the first 581 patients. (p=0.24). Difficulty obtaining access and a knotted catheter support the need for flouroscopy and ultrasound guidance in high volume services. <div>Overall our adverse event rate is comparable to rates described in the literature, and supports our current practice as safe. However rigorous attention should be paid to how and why events are described as complications.en_GB
dc.subjectRight Heart Catheterisationen_GB
dc.subjectComplicationen_GB
dc.subjectAnti Coagulationen_GB
dc.date.available2013-10-22T20:26:51Z-
dc.date.issued2013-10-22-
dc.date.accessioned2013-10-22T20:26:51Z-
dc.conference.date2013en_GB
dc.conference.name24th International Nursing Research Congressen_GB
dc.conference.hostSigma Theta Tau International, the Honor Society of Nursingen_GB
dc.conference.locationPrague, Czech Republicen_GB
dc.description24th International Nursing Research Congress Theme: Bridge the Gap Between Research and Practice Through Collaboration. Held at the Hilton Prague Hotel.en_GB
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission.en_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.